FDA grants emergency use authorisation to Quidel for first antigen test for Covid-19

The emergency use authorisation was issued late Friday to Quidel for the Sofia 2 SARS Antigen FIA, the agency said


Reuters May 09, 2020
PHOTO: FILE

WASHINGTON DC: The US Food and Drug Administration (FDA) on Saturday approved emergency use authorisation (EUA) to Quidel Corp for the first Covid-19 antigen test.

The emergency use authorisation was issued late Friday to Quidel for the Sofia 2 SARS Antigen FIA, the agency said.

NIBD's passive immunisation technique gets US drug agency's nod for clinical trials

The FDA said the authorisation is for an antigen test, which is a new type of diagnostic test designed for rapid detection of the virus that causes Covid-19.

The FDA on Friday also authorised the first diagnostic test for the new coronavirus that allows patients to collect saliva samples at home.

COMMENTS

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ

E-Publications

Most Read